Bausch + Lomb to Return Recalled Intraocular Lenses to Market
Bausch + Lomb announced plans to bring its recalled enVista intraocular lenses (IOLs) back to the market after resolving the issue that led to a
Bausch + Lomb announced plans to bring its recalled enVista intraocular lenses (IOLs) back to the market after resolving the issue that led to a
Field Medical announced it closed a $40 million Series A funding round to accelerate the development of its pulsed field ablation (PFA) technology. The Cardiff-by-the-Sea,
Elon Musk’s Neuralink is reportedly looking to raise $500 million at a pre-money valuation of $8.5 billion, as it continues to make strides in the
Biolinq has secured $100 million in Series C funding to further develop its biosensor platform, which includes the first intradermal glucose sensor that integrates activity
Swiss medtech firm Ypsomed has agreed to sell its diabetes business and insulin delivery technologies to TecMed for approximately $517.7 million. The deal includes Ypsomed
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
